NAVITAS SEMICONDUCTOR CORP (NVTS)

US63942X1063 - Common Stock

4  +0.03 (+0.76%)

Premarket: 4.08 +0.08 (+2%)

Fundamental Rating

4

NVTS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. While NVTS has a great health rating, there are worries on its profitability. NVTS shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

In the past year NVTS has reported negative net income.
NVTS had a negative operating cash flow in the past year.
In the past 5 years NVTS reported 4 times negative net income.
NVTS had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

NVTS's Return On Assets of -29.95% is on the low side compared to the rest of the industry. NVTS is outperformed by 83.02% of its industry peers.
The Return On Equity of NVTS (-38.21%) is worse than 73.58% of its industry peers.
Industry RankSector Rank
ROA -29.95%
ROE -38.21%
ROIC N/A
ROA(3y)-21.41%
ROA(5y)-59.25%
ROE(3y)-83.98%
ROE(5y)-189.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NVTS has a Gross Margin of 39.10%. This is in the lower half of the industry: NVTS underperforms 62.26% of its industry peers.
NVTS's Gross Margin has improved in the last couple of years.
NVTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.59%
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

NVTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
NVTS has more shares outstanding than it did 1 year ago.
There is no outstanding debt for NVTS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 3.07 indicates that NVTS is not in any danger for bankruptcy at the moment.
NVTS has a Altman-Z score (3.07) which is comparable to the rest of the industry.
NVTS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.07
ROIC/WACCN/A
WACC12.54%

2.3 Liquidity

A Current Ratio of 4.14 indicates that NVTS has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.14, NVTS is in the better half of the industry, outperforming 66.04% of the companies in the same industry.
NVTS has a Quick Ratio of 3.68. This indicates that NVTS is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 3.68, NVTS is doing good in the industry, outperforming 69.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 3.68

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.57% over the past year.
The Revenue has grown by 109.43% in the past year. This is a very strong growth!
Measured over the past years, NVTS shows a very strong growth in Revenue. The Revenue has been growing by 88.57% on average per year.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q33.33%
Revenue 1Y (TTM)109.43%
Revenue growth 3Y88.57%
Revenue growth 5YN/A
Revenue growth Q2Q110.99%

3.2 Future

NVTS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.46% yearly.
The Revenue is expected to grow by 54.53% on average over the next years. This is a very strong growth
EPS Next Y5.78%
EPS Next 2Y30.49%
EPS Next 3Y33.52%
EPS Next 5Y46.46%
Revenue Next Year43.43%
Revenue Next 2Y60%
Revenue Next 3Y57.22%
Revenue Next 5Y54.53%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVTS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NVTS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as NVTS's earnings are expected to grow with 33.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.49%
EPS Next 3Y33.52%

0

5. Dividend

5.1 Amount

NVTS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NAVITAS SEMICONDUCTOR CORP

NASDAQ:NVTS (5/14/2024, 7:00:02 PM)

Premarket: 4.08 +0.08 (+2%)

4

+0.03 (+0.76%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap732.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.95%
ROE -38.21%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 39.1%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.14
Quick Ratio 3.68
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y5.78%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)109.43%
Revenue growth 3Y88.57%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y